332 related articles for article (PubMed ID: 36703555)
1. Multifunctional Nano-Biomaterials for Cancer Therapy via Inducing Enhanced Immunogenic Cell Death.
Chen Q; Li C; Wang Q
Small Methods; 2023 May; 7(5):e2201457. PubMed ID: 36703555
[TBL] [Abstract][Full Text] [Related]
2. Promotion of ICD via Nanotechnology.
Qin Y; Zhang H; Li Y; Xie T; Yan S; Wang J; Qu J; Ouyang F; Lv S; Guo Z; Wei H; Yu CY
Macromol Biosci; 2023 Sep; 23(9):e2300093. PubMed ID: 37114599
[TBL] [Abstract][Full Text] [Related]
3. Stimuli-responsive nanodelivery systems for amplifying immunogenic cell death in cancer immunotherapy.
Xu W; Liu W; Yang J; Lu J; Zhang H; Ye D
Immunol Rev; 2024 Jan; 321(1):181-198. PubMed ID: 37403660
[TBL] [Abstract][Full Text] [Related]
4. Biomaterials That Induce Immunogenic Cell Death.
Li D; Liu S; Ma Y; Liu S; Liu Y; Ding J
Small Methods; 2023 May; 7(5):e2300204. PubMed ID: 37116170
[TBL] [Abstract][Full Text] [Related]
5. Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy.
Gao J; Wang WQ; Pei Q; Lord MS; Yu HJ
Acta Pharmacol Sin; 2020 Jul; 41(7):986-994. PubMed ID: 32317755
[TBL] [Abstract][Full Text] [Related]
6. Recent progress in stimuli-responsive nanosystems for inducing immunogenic cell death.
Banstola A; Poudel K; Kim JO; Jeong JH; Yook S
J Control Release; 2021 Sep; 337():505-520. PubMed ID: 34314800
[TBL] [Abstract][Full Text] [Related]
7. Reinforcing the immunogenic cell death to enhance cancer immunotherapy efficacy.
Yu S; Xiao H; Ma L; Zhang J; Zhang J
Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188946. PubMed ID: 37385565
[TBL] [Abstract][Full Text] [Related]
8. Amplifying "eat me signal" by immunogenic cell death for potentiating cancer immunotherapy.
Xi Y; Chen L; Tang J; Yu B; Shen W; Niu X
Immunol Rev; 2024 Jan; 321(1):94-114. PubMed ID: 37550950
[TBL] [Abstract][Full Text] [Related]
9. Emerging photodynamic nanotherapeutics for inducing immunogenic cell death and potentiating cancer immunotherapy.
Zhang S; Wang J; Kong Z; Sun X; He Z; Sun B; Luo C; Sun J
Biomaterials; 2022 Mar; 282():121433. PubMed ID: 35202933
[TBL] [Abstract][Full Text] [Related]
10. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
[TBL] [Abstract][Full Text] [Related]
11. Nano Delivery of Chemotherapeutic ICD Inducers for Tumor Immunotherapy.
Guo J; Zou Y; Huang L
Small Methods; 2023 May; 7(5):e2201307. PubMed ID: 36604976
[TBL] [Abstract][Full Text] [Related]
12. Combination Cancer Immunotherapy of Nanoparticle-Based Immunogenic Cell Death Inducers and Immune Checkpoint Inhibitors.
Qi J; Jin F; Xu X; Du Y
Int J Nanomedicine; 2021; 16():1435-1456. PubMed ID: 33654395
[TBL] [Abstract][Full Text] [Related]
13. Nanotechnology-enabled immunogenic cell death for improved cancer immunotherapy.
Li W; Jiang Y; Lu J
Int J Pharm; 2023 Mar; 634():122655. PubMed ID: 36720448
[TBL] [Abstract][Full Text] [Related]
14. Cancer Immunotherapy Elicited by Immunogenic Cell Death Based on Smart Nanomaterials.
Yang M; Zhang C; Wang R; Wu X; Li H; Yoon J
Small Methods; 2023 May; 7(5):e2201381. PubMed ID: 36609838
[TBL] [Abstract][Full Text] [Related]
15. Bioactive Peptide Nanodrugs Based on Supramolecular Assembly for Boosting Immunogenic Cell Death-Induced Cancer Immunotherapy.
Liu Y; Chang R; Xing R; Yan X
Small Methods; 2023 May; 7(5):e2201708. PubMed ID: 36720041
[TBL] [Abstract][Full Text] [Related]
16. Polymeric Nanosystems for Immunogenic Cell Death-Based Cancer Immunotherapy.
Fu L; Zhou X; He C
Macromol Biosci; 2021 Jul; 21(7):e2100075. PubMed ID: 33885225
[TBL] [Abstract][Full Text] [Related]
17. Rediscovery of nanoparticle-based therapeutics: boosting immunogenic cell death for potential application in cancer immunotherapy.
Yang S; Sun IC; Hwang HS; Shim MK; Yoon HY; Kim K
J Mater Chem B; 2021 May; 9(19):3983-4001. PubMed ID: 33909000
[TBL] [Abstract][Full Text] [Related]
18. Immunogenic cell death in cancer therapy: Present and emerging inducers.
Zhou J; Wang G; Chen Y; Wang H; Hua Y; Cai Z
J Cell Mol Med; 2019 Aug; 23(8):4854-4865. PubMed ID: 31210425
[TBL] [Abstract][Full Text] [Related]
19. Biomimetic Active Materials Guided Immunogenic Cell Death for Enhanced Cancer Immunotherapy.
Huang G; Liu L; Pan H; Cai L
Small Methods; 2023 May; 7(5):e2201412. PubMed ID: 36572642
[TBL] [Abstract][Full Text] [Related]
20. Nano-sized drug delivery systems to potentiate the immune checkpoint blockade therapy.
Shim MK; Song SK; Jeon SI; Hwang KY; Kim K
Expert Opin Drug Deliv; 2022 Jun; 19(6):641-652. PubMed ID: 35603410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
